1068 related articles for article (PubMed ID: 16585183)
1. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
2. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
3. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
4. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
5. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Hsu CP; Hsu NY; Lee LW; Ko JL
Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
[TBL] [Abstract][Full Text] [Related]
6. Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.
Chen W; Xiao BK; Liu JP; Chen SM; Tao ZZ
Cancer Sci; 2010 Aug; 101(8):1769-76. PubMed ID: 20545697
[TBL] [Abstract][Full Text] [Related]
7. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
8. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Pantic M; Zimmermann S; Waller CF; Martens UM
Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF
Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938
[TBL] [Abstract][Full Text] [Related]
11. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
12. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
13. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
[TBL] [Abstract][Full Text] [Related]
14. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
16. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
17. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
18. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
19. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
